All lobbying filings

BAUSCH HEALTH COMPANIES

Lobbying for BAUSCH HEALTH COMPANIES

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $160,000.00 expenses · posted Oct 2, 2025

Official filing document

Bills named in this filing 1

HR 8267
Old Drugs, New Cures Act

Lobbying activity 1

Health Issues

General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.